Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Minimal Residual Disease
Clinical trial register · China

Minimal Residual Disease Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Beijing 5 Wuhan 1 Shanghai 1 Hangzhou 1 Shijiazhuang 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5 Wuhan1 Shanghai1 Hangzhou1 Shijiazhuang1
All 6 locations
Target enrolment
to

Minimal Residual Disease trials in China

10 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer
NCT07894458Lung Neoplasms, Neoadjuvant Therapy, Immunotherapy, Minimal Residual Disease
Peking University People's Hospital
Not applicable
100
Beijing
2026-08-12
Not yet open
Tongji Hospital
Not applicable
276
Wuhan
2025-12-31
Recruiting
Peking University People's Hospital
Observational
100
Beijing
2025-05-08
Not yet open
Shanghai Zhongshan Hospital
Observational
66
Shanghai
2025-04-20
Recruiting
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807Non-small Cell Lung Cancer, Minimal Residual Disease, Adaptive Treatment
Peking University People's Hospital
Not applicable
1,000
Beijing
2025-03-25
Recruiting
VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
NCT06536959Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes, Minimal Residual Disease
Beijing 302 Hospital
Phase 2
67
Beijing
2024-07-18
Recruiting
First Affiliated Hospital of Zhejiang University
Observational
210
Hangzhou
2023-12-01
Recruiting
A Study of Chidamide With AZA in MRD Positive AML After Transplant
NCT06066905AML, Adult, Minimal Residual Disease
Guangdong Provincial People's Hospital
Not applicable
60
Guangzhou
2023-10-26
Recruiting
Minimally Residual of Esophageal Cancer 001
NCT05952661Esophageal Carcinoma, Minimal Residual Disease
Hebei Medical University Fourth Hospital
Observational
56
Shijiazhuang
2023-02-22
Recruiting
Peking University People's Hospital
Observational
45
Beijing
2022-01-01
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/condition/minimal-residual-disease

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Minimal Residual Disease.

How many Minimal Residual Disease trials are recruiting in China?

8 of the 10 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Minimal Residual Disease), 10 studies
PhaseStudiesRecruitingShare
Observational5450%
Not applicable4340%
Phase 21110%

Most active sponsors

Lead sponsors with the most studies (Minimal Residual Disease)
Lead sponsorStudiesRecruiting
Peking University People's Hospital44
Beijing 302 Hospital11
First Affiliated Hospital of Zhejiang University11
Guangdong Provincial People's Hospital11
Hebei Medical University Fourth Hospital11
Shanghai Zhongshan Hospital10
Tongji Hospital10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.